A detailed history of New Square Capital LLC transactions in Johnson & Johnson stock. As of the latest transaction made, New Square Capital LLC holds 147 shares of JNJ stock, worth $24,228. This represents 0.0% of its overall portfolio holdings.

Number of Shares
147
Previous 426 65.49%
Holding current value
$24,228
Previous $67,000 68.66%
% of portfolio
0.0%
Previous 0.01%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

SELL
$144.38 - $157.78 $40,282 - $44,020
-279 Reduced 65.49%
147 $21,000
Q1 2024

May 08, 2024

SELL
$155.22 - $162.74 $51,843 - $54,355
-334 Reduced 43.95%
426 $67,000
Q4 2023

Feb 01, 2024

BUY
$145.6 - $158.88 $35,235 - $38,448
242 Added 46.72%
760 $119,000
Q3 2023

Nov 03, 2023

SELL
$155.75 - $174.48 $32,084 - $35,942
-206 Reduced 28.45%
518 $80,000
Q2 2023

Aug 03, 2023

SELL
$154.35 - $166.11 $23,461 - $25,248
-152 Reduced 17.35%
724 $119,000
Q1 2023

May 01, 2023

BUY
$151.05 - $180.26 $59,362 - $70,842
393 Added 81.37%
876 $135,000
Q4 2022

Feb 06, 2023

SELL
$160.2 - $179.79 $36,365 - $40,812
-227 Reduced 31.97%
483 $85,000
Q3 2022

Oct 25, 2022

SELL
$161.33 - $179.52 $26,619 - $29,620
-165 Reduced 18.86%
710 $116,000
Q2 2022

Jul 26, 2022

SELL
$168.19 - $186.01 $16,819 - $18,601
-100 Reduced 10.26%
875 $155,000
Q1 2022

May 10, 2022

SELL
$158.14 - $179.59 $93,777 - $106,496
-593 Reduced 37.82%
975 $173,000
Q4 2021

Jan 26, 2022

BUY
$155.93 - $173.01 $11,694 - $12,975
75 Added 5.02%
1,568 $268,000
Q3 2021

Nov 08, 2021

BUY
$161.5 - $179.47 $54,587 - $60,660
338 Added 29.26%
1,493 $241,000
Q2 2021

Jul 28, 2021

BUY
$159.48 - $171.07 $91,382 - $98,023
573 Added 98.45%
1,155 $190,000
Q4 2020

Feb 04, 2021

SELL
$137.11 - $157.38 $2,056 - $2,360
-15 Reduced 2.51%
582 $92,000
Q2 2020

Aug 05, 2020

SELL
$128.81 - $155.51 $249,891 - $301,689
-1,940 Reduced 76.47%
597 $84,000
Q1 2020

May 08, 2020

BUY
$111.14 - $153.99 $215,611 - $298,740
1,940 Added 324.96%
2,537 $333,000
Q3 2019

Oct 15, 2019

SELL
$126.95 - $142.14 $135,709 - $151,947
-1,069 Reduced 64.17%
597 $77,000
Q2 2019

Aug 20, 2019

SELL
$131.15 - $144.24 $5,639 - $6,202
-43 Reduced 2.52%
1,666 $232,000
Q1 2019

Apr 25, 2019

SELL
$125.72 - $139.79 $10,183 - $11,322
-81 Reduced 4.53%
1,709 $239,000
Q4 2018

Jan 22, 2019

SELL
$122.84 - $147.84 $7,738 - $9,313
-63 Reduced 3.4%
1,790 $231,000
Q3 2018

Oct 19, 2018

BUY
$121.58 - $142.88 $1,823 - $2,143
15 Added 0.82%
1,853 $256,000
Q2 2018

Jul 23, 2018

SELL
$119.4 - $131.76 $8,716 - $9,618
-73 Reduced 3.82%
1,838 $231,000
Q1 2018

Apr 24, 2018

BUY
$125.1 - $148.14 $2,251 - $2,666
18 Added 0.95%
1,911 $245,000
Q4 2017

Jan 29, 2018

SELL
$131.22 - $143.62 $4.26 Million - $4.67 Million
-32,492 Reduced 94.49%
1,893 $264,000
Q3 2017

Nov 07, 2017

BUY
$129.47 - $135.38 $4.45 Million - $4.66 Million
34,385
34,385 $221,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $431B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track New Square Capital LLC Portfolio

Follow New Square Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Square Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Square Capital LLC with notifications on news.